Link Adds CEO and CMO as Lead Program Enters Clinic

Company Link Cell Therapies Event Type Leadership Appointment Modality Logic-Gated CAR-T Asset LNK001 Target Not Applicable Disease Area Solid and Hematologic Cancers Summary Link Cell Therapies appointed Jie D’Elia chief executive officer and director, Friedrich Graf Finckenstein chief medical officer and co-founder Brian Slingerland executive…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *